153 related articles for article (PubMed ID: 11673745)
21. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
[TBL] [Abstract][Full Text] [Related]
22. Neonatal imprinting and hepatic cytochrome P-450. Immunochemical evidence for the presence of a sex-dependent and neonatally imprinted form(s) of hepatic cytochrome P-450.
Chao H; Chung LW
Mol Pharmacol; 1982 May; 21(3):744-52. PubMed ID: 7110121
[No Abstract] [Full Text] [Related]
23. Effect of breed and gender on bovine liver cytochrome P450 3A (CYP3A) expression and inter-species comparison with other domestic ruminants.
Dacasto M; Eeckhoutte C; Capolongoa F; Dupuy J; Carletti M; Calléja C; Nebbia C; Alvinerie M; Galtier P
Vet Res; 2005; 36(2):179-90. PubMed ID: 15720971
[TBL] [Abstract][Full Text] [Related]
24. Genetics. SNP-ing drugs to size.
Gura T
Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
[No Abstract] [Full Text] [Related]
25. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease.
Lown K; Kolars J; Turgeon K; Merion R; Wrighton SA; Watkins PB
Clin Pharmacol Ther; 1992 Mar; 51(3):229-38. PubMed ID: 1544283
[TBL] [Abstract][Full Text] [Related]
26. Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.
Hunt CM; Westerkam WR; Stave GM; Wilson JA
Mech Ageing Dev; 1992 Jun; 64(1-2):189-99. PubMed ID: 1630156
[TBL] [Abstract][Full Text] [Related]
27. [Molecular mechanism of the expression and modulation of CYP3A gene].
Wang JS; Zhou HH
Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
[No Abstract] [Full Text] [Related]
28. Characterization of hepatic cytochrome p4503A activity in patients with end-stage renal disease.
Dowling TC; Briglia AE; Fink JC; Hanes DS; Light PD; Stackiewicz L; Karyekar CS; Eddington ND; Weir MR; Henrich WL
Clin Pharmacol Ther; 2003 May; 73(5):427-34. PubMed ID: 12732843
[TBL] [Abstract][Full Text] [Related]
29. Thin-layer chromatographic analysis of human CYP3A-catalyzed testosterone 6 beta-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 1998; 107():153-61. PubMed ID: 14577225
[No Abstract] [Full Text] [Related]
30. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity.
Watkins PB; Turgeon DK; Saenger P; Lown KS; Kolars JC; Hamilton T; Fishman K; Guzelian PS; Voorhees JJ
Clin Pharmacol Ther; 1992 Sep; 52(3):265-73. PubMed ID: 1526083
[TBL] [Abstract][Full Text] [Related]
31. Oral erythromycin and the risk of sudden death.
Amory JK; Amory DW
N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
[No Abstract] [Full Text] [Related]
32. Cytochrome P450 3A4 activity after surgical stress.
Haas CE; Kaufman DC; Jones CE; Burstein AH; Reiss W
Crit Care Med; 2003 May; 31(5):1338-46. PubMed ID: 12771600
[TBL] [Abstract][Full Text] [Related]
33. Grapefruits and drugs: when is statistically significant clinically significant?
Abernethy DR
J Clin Invest; 1997 May; 99(10):2297-8. PubMed ID: 9153265
[No Abstract] [Full Text] [Related]
34. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
James MO; Lou Z; Rowland-Faux L; Celander MC
Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
[TBL] [Abstract][Full Text] [Related]
35. Amlodipine has a minor effect on cyclosporine metabolism.
McGregor DO; Bailey RR; Robson RA
Clin Nephrol; 1997 Nov; 48(5):336. PubMed ID: 9403222
[No Abstract] [Full Text] [Related]
36. Induction of cytochrome P450 3A by metyrapone in human hepatocyte culture.
Wright MC; Maurel P; Paine AJ
Hum Exp Toxicol; 1996 Mar; 15(3):203-4. PubMed ID: 8839205
[No Abstract] [Full Text] [Related]
37. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
Kurnik D; Wood AJ; Wilkinson GR
Clin Pharmacol Ther; 2006 Sep; 80(3):228-34. PubMed ID: 16952489
[TBL] [Abstract][Full Text] [Related]
38. Cisapride (Prepulsid): interactions with grapefruit and drugs.
Morawiecka I
CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
[No Abstract] [Full Text] [Related]
39. The mechanism of cyclosporine toxicity induced by clarithromycin.
Spicer ST; Liddle C; Chapman JR; Barclay P; Nankivell BJ; Thomas P; O'Connell PJ
Br J Clin Pharmacol; 1997 Feb; 43(2):194-6. PubMed ID: 9131953
[TBL] [Abstract][Full Text] [Related]
40. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
Chalasani N; Gorski JC; Patel NH; Hall SD; Galinsky RE
Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
